Medicare patients with advanced cancers will now have access to a more 21st century diagnostic: gene-sequencing tests to match them with the right drugs.
Medicare patients with advanced cancers will now have access to a more 21st century diagnostic: gene-sequencing tests to match them with the right drugs.
